Effectiveness of Molecular?Targeted Chemotherapy in Ameloblastomas: A Systematic Review

Simple item page
dc.contributor.authorYoithapprabhunath, Thuckanaickenpalayam R.en_US
dc.contributor.authorSrichinthu, Kenniyan K.en_US
dc.contributor.authorGupta, Deepaken_US
dc.contributor.authorSingh, Dikshaen_US
dc.contributor.authorPasupuleti, Swethaen_US
dc.contributor.authorNirmal, Ramdas M.en_US
dc.date.accessioned2023-08-09T06:18:28Z
dc.date.available2023-08-09T06:18:28Z
dc.date.issued2022-09
dc.description.abstractAmeloblastoma is a benign, locally aggressive neoplasm that needs extensive surgical resection. The goal of this article is to obtain an in?depth review of benign ameloblastomas to determine the available level of evidence and the possible benefit of targeted therapeutics for the treatment of ameloblastoma and BRAF V600E mutation in ameloblastoma. An electronic literature search was conducted according to PRISMA guidelines in PubMed/MEDLINE, EBSCO, and Web of Science for eligible studies published between 1975 and 2021. The systematic review is registered with INPLASY (INPLASY202260018). The review included 2 case series and 17 case reports. The histopathological type, anatomic location, expression of BRAF mutation, additional mutations, and molecular?targeted therapies of the 19 reviewed articles were summarized and tabulated. Interestingly, the majority of the primary site of ameloblastoma was located in the mandible (80.9%) compared to the maxilla (17%). The tumour size was reported in nine of the included studies. Most of the included studies in the review exhibited ameloblastoma with BRAF V600E mutations and responded to molecular?targeted therapies. Molecular therapies employing BRAF and/or MEK inhibitors in ameloblastoma with BRAF V600E mutations proved to be an appropriate treatment based on the limited available evidence. It is essential further to deepen our understanding at then_US
dc.identifier.affiliationsDepartment of Oral and Maxillofacial Pathology, Vivekanandha Dental College for Women, Tamil Naduen_US
dc.identifier.affiliationsDepartment of Oral and Maxillofacial Pathology, KSR Institute of Dental Science and Research, Tamil Naduen_US
dc.identifier.affiliationsDepartment of Oral Medicine and Radiology, M.M. College of Dental Sciences and Research, Mullana, Haryanaen_US
dc.identifier.affiliationsDepartment of Oral and Maxillofacial Pathology, King George Medical College, Uttar Pradeshen_US
dc.identifier.affiliationsDepartment of Oral and Maxillofacial Pathology, Vishnu Dental College, Andhra Pradeshen_US
dc.identifier.affiliationsDepartment of Oral and Maxillofacial Pathology, Cuddalore Government Dental College and Hospital, Tamil Nadu, Indiaen_US
dc.identifier.citationYoithapprabhunath Thuckanaickenpalayam R., Srichinthu Kenniyan K., Gupta Deepak, Singh Diksha, Pasupuleti Swetha, Nirmal Ramdas M.. Effectiveness of Molecular?Targeted Chemotherapy in Ameloblastomas: A Systematic Review . Indian Journal of Dental Research. 2022 Sep; 33(3): 323-331en_US
dc.identifier.issn1998-3603
dc.identifier.issn0970-9290
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/222404
dc.languageenen_US
dc.publisherWolters Kluwer - Medknowen_US
dc.relation.issuenumber3en_US
dc.relation.volume33en_US
dc.source.urihttps://doi.org/10.4103/ijdr.ijdr_456_22en_US
dc.subjectBRAF V600Een_US
dc.subjectMAID regimenen_US
dc.subjectmetastatic ameloblastomaen_US
dc.subjectmolecular?targeted therapyen_US
dc.subjectpulmonary ameloblastomaen_US
dc.titleEffectiveness of Molecular?Targeted Chemotherapy in Ameloblastomas: A Systematic Reviewen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IJDR2022v33n3p323.pdf
Size:
660.36 KB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Dental Research